Clinical trial
Identification of Clinical and Pharmacogenetic Factors Predictive of Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation.
NCT04297150 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Clinical and Pharmacogenetic Factors Predictive of Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation.
- Lead sponsor
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 18, 2020
- Completion date
- September 30, 2023
- Enrollment
- 700 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.